No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
High Tide Inc. operates extensively in the global cannabis retail market, with its business activities reaching across Canada, Europe, the United States, and other international regions. The company also specializes in the design, manufacturing, and distribution of various smoking accessories and cannabis-oriented lifestyle products. Its operations include the wholesale and direct retail of cannabis products, alongside the establishment and franchising of licensed retail cannabis dispensaries. Additionally, High Tide Inc. provides data analytics services and oversees the online platforms Grasscity.com and CBDcity.com. As of October 25, 2022, the company managed 149 retail locations situated in Canadian provinces such as Ontario, Alberta, British Columbia, Manitoba, and Saskatchewan. Founded in 2009, the enterprise, originally named High Tide Ventures Inc., officially became High Tide Inc. in October 2018 and maintains its headquarters in Calgary, Canada.
www.hightideinc.comNo one on the platform currently holds 2LYA.F.
No tracked institution reports a position in 2LYA.F as of their last filing.
No one on the platform has traded 2LYA.F yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | 13.7% | 48.1% | ||||
| Profit Margin % | -8.5% | -11.5% | -18.3% | |||
| Free Cash Flow Margin % | 2.2% | 0.3% | -20.7% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $752M | +27.9% | $0.05 | $0.05–$0.05 | — | 1 |
| 2027 | $830M | +10.3% | $0.21 | $0.21–$0.22 | — | 1 |
| 2028 | $885M | +6.7% | $0.29 | $0.28–$0.29 | — | 1 |
| 2029 | $913M | +3.2% | $0.43 | $0.42–$0.44 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-09-14 | $0.01 | $0.01 | +29.6% |
| 2026-06-15 | $-0.01 | $0.01 | +142.1% |
| 2026-03-17 | $-0.00 | $0.01 | +400.5% |
| 2026-01-29 | $0.00 | $-0.40 | -13064.7% |
| 2025-09-15 | $-0.00 | $0.01 | +245.3% |
| 2025-06-16 | $-0.02 | $-0.02 | +2.4% |
| 2025-03-17 | $-0.02 | $-0.02 | -30.3% |
| 2025-01-27 | $-0.01 |
| $-0.04 |
| -247.2% |
| $118M |
| — |
| ILM1.DEMedios AG | $10.30 | +0.39% | $263M | — |
| M12.DEM1 Kliniken AG | $20.60 | -2.37% | $387M | — |
Source: Financial Modeling Prep · peers by sector/industry